Emcure Pharmaceuticals Ltd Annually Results

Gross Sales

7,896

6,658.25

5,985.81

5,855.39

6,056.42

Excise Duty

0

0

0

0

0

Net Sales

7,896

6,658.25

5,985.81

5,855.39

6,056.42

Other Operating Income

0

0

0

0

0

Other Income

67.26

56.99

45.91

63.47

35.39

Total Income

7,963.26

6,715.24

6,031.72

5,918.86

6,091.81

Total Expenditure

6,432

5,438.46

4,810.78

4,525.48

4,913.04

PBIDT

1,531.26

1,276.78

1,220.94

1,393.38

1,178.77

Interest

175.78

237.15

213.61

175.98

198.13

PBDT

1,355.48

1,039.64

1,007.33

1,217.4

980.64

Depreciation

384.13

312.41

260.12

244.86

323.31

Minority Interest Before NP

0

0

0

0

0

Tax

292.16

209.64

173.3

286.05

200.89

Deferred Tax

-28.28

-9.99

12.07

-16.06

37.84

Reported Profit After Tax

707.47

527.58

561.85

702.56

418.59

Minority Interest After NP

26.14

29.39

29.83

40.36

0

Net Profit after Minority Interest

681.33

498.18

532.02

662.2

418.59

Extra-ordinary Items

-7.26

-7.07

-4.62

0

-56.42

Adjusted Profit After Extra-ordinary item

688.59

505.25

536.64

662.2

475.01

EPS (Unit Curr.)

36.43

27.54

29.42

36.62

21.68

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

30

0

0

0

10

Equity

189.48

181.15

180.85

180.85

180.85

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.39

19.17

20.39

23.79

19.46

PBDTM(%)

17.16

15.61

16.82

20.79

16.19

PATM(%)

8.95

7.92

9.38

11.99

6.91